Atorvastatin Sales Data
Last updated: February 2014 (updated quarterly).
The following data shows atorvastatin U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q2 2013 | 99 ( 11) |
$172,239 | -10.88% | 7,012 | 9.77% |
| Q1 2013 | 88 (4) |
$193,260 | -1.47% | 6,388 | 4.70% |
| Q4 2012 | 84 ( 15) |
$196,153 | 15.04% | 6,101 | 10.31% |
| Q3 2012 | 99 (85) |
$170,506 | -78.25% | 5,531 | 30.20% |
| Q2 2012 | 14 (5) |
$784,007 | -17.68% | 4,248 | 12.83% |
| Q1 2012 | 9 (15) |
$952,407 | 88.56% | 3,765 | 116.38% |
| Q4 2011 | 24 ( ) |
$505,092 | n/a | 1,740 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
